The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.
We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.
The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.
At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.
Looking forward to speaking at the AMP/NIH Knowledge Portal webinar on proteomics + genomics for diabetes and cardiometabolic diseases!
The University Flag is lowered today, Sept. 16, 2026, in honour of Prof. Emeritus Arak M. Mathai, Dept. of Mathematics and Statistics, Prof. Varoujan Yaylayan, Dept. of Food Science and Agricultural Chemistry, and Prof. Apostolos Papageorgiou, Dept. of Pediatrics.
Congratulations to @LDI_ILD trainees Mehdi Haghi and Nicolas Terzopoulos and all other recipients of the 2026 D2R Scholar Awards.
We are very thankful to D2R for their support. Congratulations to Johanna Toth on the 2026 D2R Scholar Award: 'Lipid Nanoparticle-Mediated mRNA Therapy for Sickle Cell Disease Through Targeted Delivery to Erythroid Precursors'.
🎉 Congratulations to the recipients of the 2026 D2R Scholar Awards!
This year, D2R is supporting 30 outstanding Master's and Doctoral students conducting #RNAResearch at @McGillU, @uOttawa, @UBC, @USherbrooke.
🔗https://www.mcgill.ca/dna-to-rna/channels/news/d2r-continues-invest-canadas-next-generation-rna-research-leaders-374291